Excluding the CpGs in MYO1G eliminated the positive association of Score-15 and Score-19 with lung cancer risk, suggesting that prenatal-associated CpGs on MYO1G might have a notable association with lung cancer risk. This evidence concerns the gene MYO1G and lung carcinoma.